SHARON SNOVER: Open Payments
NPI 1972663417 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 33 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $291 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $237 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $123 |
| Madrigal Pharmaceuticals | 2 | $90 |
| Gilead Sciences, Inc. | 4 | $83 |
| Janssen Biotech, Inc. | 1 | $24 |
| GENZYME CORPORATION | 1 | $22 |
| PFIZER INC. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
Products named: ENTYVIO, RINVOQ, REZDIFFRA, MAVYRET, SKYRIZI, TREMFYA, DUPIXENT, VELSIPITY.
Industry payments across NC — which companies pay providers there.
